Ihssan Alalem

Dr. Ihssan Alalem

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2019 in American Journal of Case Reports
Verified
Journal Article
Closed access
PDF file
MHMayar Helaly
Mayar Helaly
DSDalia Sriwi
Dalia Sriwi
WAWijdan S. Alkholaidi
Wijdan S. Alkholaidi
RARaghed Almamlouk
Raghed Almamlouk
AEAmany Elshaer
Amany Elshaer
IAIhssan Alalem
Ihssan Alalem
BACKGROUND:Pancreaticoduodenectomy (Whipple procedure) is an established surgical procedure for the treatment of carcinoma of the head of the pancreas. Modifications to this procedure include gastropancreaticoduodenectomy, which includes the removal ...

20 July 2026 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
GAGhedaa A. Armosh
Ghedaa A. Armosh
KAKhalid Alnajjar
Khalid Alnajjar
MAMarwan Alaswad
Marwan Alaswad
AAAhmed Ayman Azzam
Ahmed Ayman Azzam
AAAyman Aldeheshi
Ayman Aldeheshi
IAIhssan Alalem
Ihssan Alalem
Introduction: Jejunal carcinoma, a rare subset of small bowel adenocarcinomas, is characterized by its aggressive nature and nonspecific clinical presentation. The prognosis becomes particularly poor when peritoneal carcinomatosis is present. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a treatment performed with curative intent for select patients with gastrointestinal cancers, particularly those with limited peritoneal metastases. Case description: A 51-year-old female presented with progressive symptoms of small bowel obstruction and gastrointestinal bleeding, diagnosed as jejunal adenocarcinoma with limited peritoneal carcinomatosis. She underwent CRS combined with HIPEC. Postoperative recovery was uneventful, with imaging studies and pathological analysis confirming complete tumor resection. Discussion and conclusion: HIPEC and CRS have shown potential in managing peritoneal carcinomatosis. However, their efficacy in rare cancers, such as jejunal carcinoma, remains underexplored. Studies show encouraging outcomes for small bowel adenocarcinoma treated with CRS and HIPEC, emphasizing patient selection and multidisciplinary management.